{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T21:35:31Z","timestamp":1785188131418,"version":"3.55.0"},"reference-count":24,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T00:00:00Z","timestamp":1686096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Tuberculosis (TB) is a multisystemic contagious disease produced by Mycobacterium tuberculosis complex bacteria (MTBC), with a prevalence of 65:100,000 inhabitants in Romania (six times higher than the European average). The diagnosis usually relies on the detection of MTBC in culture. Although this is a sensitive method of detection and remains the \u201cgold standard\u201d, the results are obtained after several weeks. Nucleic acid amplification tests (NAATs), being a quick and sensitive method, represent progress in the diagnosis of TB. The aim of this study is to assess the assumption that NAAT using Xpert MTB\/RIF is an efficient method of TB diagnosis and has the capacity to reduce false-positive results. Pathological samples from 862 patients with TB suspicion were tested using microscopic examination, molecular testing and bacterial culture. The results show that the Xpert MTB\/RIF Ultra test has a sensitivity of 95% and a specificity of 96.4% compared with 54.8% sensitivity and 99.5% specificity for Ziehl\u2013Neelsen stain microscopy, and an average of 30 days gained in the diagnosis of TB compared with bacterial culture. The implementation of molecular testing in TB laboratories leads to an important increase in early diagnostics of the disease and the prompter isolation and treatment of infected patients.<\/jats:p>","DOI":"10.3390\/genes14061231","type":"journal-article","created":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T01:34:32Z","timestamp":1686188072000},"page":"1231","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The Use of Xpert MTB\/RIF Ultra Testing for Early Diagnosis of Tuberculosis: A Retrospective Study from a Single-Center Database"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6456-5770","authenticated-orcid":false,"given":"Cristian","family":"Sava","sequence":"first","affiliation":[{"name":"Faculty of Medicine and Pharmacy, University of Oradea, 410087 Oradea, Romania"},{"name":"Clinical Emergency Bihor County Hospital, 410167 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihaela","family":"Sava","sequence":"additional","affiliation":[{"name":"Clinical Emergency Bihor County Hospital, 410167 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana-Maria","family":"Dr\u0103gan","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Pharmacy, University of Oradea, 410087 Oradea, Romania"},{"name":"Clinical Emergency Bihor County Hospital, 410167 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2463-8100","authenticated-orcid":false,"given":"Alin","family":"Iuhas","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Pharmacy, University of Oradea, 410087 Oradea, Romania"},{"name":"Clinical Emergency Bihor County Hospital, 410167 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1087-3417","authenticated-orcid":false,"given":"Larisa","family":"Niula\u0219","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Pharmacy, University of Oradea, 410087 Oradea, Romania"},{"name":"Clinical Emergency Bihor County Hospital, 410167 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Marin\u0103u","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Pharmacy, University of Oradea, 410087 Oradea, Romania"},{"name":"Clinical Emergency Bihor County Hospital, 410167 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreea","family":"Balmo\u0219","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Pharmacy, University of Oradea, 410087 Oradea, Romania"},{"name":"Clinical Emergency Bihor County Hospital, 410167 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,6,7]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2022, March 04). Global Tuberculosis Report 2020. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789240013131."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Houben, R.M., and Dodd, P.J. (2016). The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling. PLoS Med., 13.","DOI":"10.1371\/journal.pmed.1002152"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0140-6736(09)60331-7","article-title":"Epidemiology of antituberculosis drug resistance 2002\u201307: An updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance","volume":"373","author":"Wright","year":"2009","journal-title":"Lancet"},{"key":"ref_4","unstructured":"European Centre for Disease Prevention and Control\/WHO Regional Office for Europe (2022, March 04). Tuberculosis Surveillance and Monitoring in Europe 2020\u20132018 Data. Available online: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/tuberculosis-surveillance-and-monitoring-europe-2020-2018-data."},{"key":"ref_5","unstructured":"(2021, November 04). Analiza de Situatie TB 2019, Available online: https:\/\/insp.gov.ro\/sites\/cnepss\/wp-content\/uploads\/2019\/04\/Analiza-de-situatie-tb2019.pdf."},{"key":"ref_6","unstructured":"Chiotan, D., and Popa, C.G. (2021, November 04). Ghidul Pentru Identificarea Suspec\u021bilor TB \u0219i Referire a Pacien\u021bilor cu TB Pentru To\u021bi Furnizorii de Servicii (Inclusiv Identificarea Activ\u0103 a Cazurilor de TB \u00een R\u00e2ndul Popula\u021biilor Vulnerabile, Available online: https:\/\/www.raa.ro\/wp-content\/uploads\/2018\/05\/Ghid-de-identificare-si-referire-a-persoanelor-suspecte-de-TB-2017-RO.pdf."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ijtb.2015.11.001","article-title":"WHO\u2019s End TB Strategy: From stopping to ending the global TB epidemic","volume":"62","author":"Uplekar","year":"2015","journal-title":"Indian J. Tuberc."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/trstmh\/trv108","article-title":"The WHO\u2019s new End TB Strategy in the post-2015 era of the Sustainable Development Goals","volume":"110","author":"Raviglione","year":"2016","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_9","unstructured":"World Health Organization (2022). Implementing the End TB Strategy: The Essentials, World Health Organization."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.21873\/invivo.13019","article-title":"Biomarker Changes in Pediatric Patients With COVID-19: A Retrospective Study from a Single Center Database","volume":"36","author":"Sava","year":"2022","journal-title":"Vivo"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Wu, C.W., Wu, Y.K., Lan, C.C., Yang, M.C., Dong, T.Q., Tzeng, I.S., and Hsiao, S.S. (2019). Impact of nucleic acid amplification test on pulmonary tuberculosis notifications and treatments in Taiwan: A 7-year single-center cohort study. BMC Infect. Dis., 19.","DOI":"10.1186\/s12879-019-4358-8"},{"key":"ref_12","unstructured":"World Health Organization (2021). Module 3: Diagnosis-rapid diagnostics for tuberculosis detention. WHO Operational Handbook on Tuberculosis, World Health Organization."},{"key":"ref_13","first-page":"CD009593","article-title":"Xpert\u00ae MTB\/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults","volume":"2014","author":"Steingart","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Iuhas, A., Jurca, C., Kozma, K., Riza, A.-L., Strea\u021b\u0103, I., Petche\u0219i, C., Dan, A., Sava, C., Balmo\u0219, A., and Marin\u0103u, C. (2023). PAH Pathogenic Variants and Clinical Correlations in a Group of Hyperphenylalaninemia Patients from North-Western Romania. Diagnostics, 13.","DOI":"10.3390\/diagnostics13081483"},{"key":"ref_15","unstructured":"Ministerul S\u0103n\u0103t\u0103\u021bii din Rom\u00e2nia (2021, November 04). Ghidul Metodologic de Implementare a Programului Na\u0163ional de Prevenire, Supraveghere \u015fi Control al Tuberculozei. Available online: http:\/\/old.ms.ro\/documente\/GHID%20Metodologic%20de%20implementare%20a%20Programului%20national%20de%20prevenire,%20supraveghere%20si%20control%20al%20tuberculozei%202015_15424_18333.pdf."},{"key":"ref_16","unstructured":"(2022, March 05). Xpert\u00ae MTB\/RIF Assay. Available online: https:\/\/www.cepheid.com\/en_US\/package-inserts\/1608."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"ofx045","DOI":"10.1093\/ofid\/ofx045","article-title":"Clinical Impact of Nucleic Acid Amplification Testing in the Diagnosis of Mycobacterium Tuberculosis: A 10-Year Longitudinal Study","volume":"4","author":"Bourgi","year":"2017","journal-title":"Open Forum Infect. Dis."},{"key":"ref_18","first-page":"94","article-title":"Counts of viable tubercle bacilli in sputum related to smear and culture gradings","volume":"49","author":"Allen","year":"1992","journal-title":"Med. Lab. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta11030","article-title":"A systematic review of rapid diagnostic tests for the detection of tuberculosis infection","volume":"11","author":"Dinnes","year":"2007","journal-title":"Health Technol. Assess."},{"key":"ref_20","unstructured":"World Health Organization (2013). Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance. Xpert MTB\/RIF Assay for the Diagnosis of Pulmonary and Extrapulmonary TB in Adults and Children: Policy Update, World Health Organization. Available online: http:\/\/apps.who.int\/iris\/handle\/10665\/112472?locale=zh."},{"key":"ref_21","unstructured":"CDC (2022, March 05). Report of an Expert Consultation on the Uses of Nucleic Acid Amplification Tests for the Diagnosis of Tuberculosis, Available online: https:\/\/www.cdc.gov\/tb\/publications\/guidelines\/amplification_tests\/considerations.htm."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1086\/599037","article-title":"Performance of nucleic acid amplification tests for diagnosis of tuberculosis in a large urban setting","volume":"49","author":"Laraque","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/cid\/ciw035","article-title":"Evaluation of Xpert MTB\/RIF Versus AFB Smear and Culture to Identify Pulmonary Tuberculosis in Patients with Suspected Tuberculosis from Low and Higher Prevalence Settings","volume":"62","author":"Luetkemeyer","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_24","unstructured":"Centers for Disease Control and Prevention (CDC) (2009). Updated guidelines for the use of nucleic acid amplification tests in the diagnosis of tuberculosis. Morb. Mortal. Wkly. Rep., 58, 7\u201310."}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/14\/6\/1231\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:50:06Z","timestamp":1760125806000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/14\/6\/1231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,7]]},"references-count":24,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["genes14061231"],"URL":"https:\/\/doi.org\/10.3390\/genes14061231","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,7]]}}}